infliximab psoriasis
Selected indexed studies
- Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events. (Drug Des Devel Ther, 2019) [PMID:31413544]
- Infliximab for psoriasis. (J Am Acad Dermatol, 2003) [PMID:12894134]
- Psoriasis. (Nat Rev Dis Primers, 2016) [PMID:27883001]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events. (2019) pubmed
- Infliximab for psoriasis. (2003) pubmed
- Psoriasis. (2016) pubmed
- Infliximab: efficacy in psoriasis. (2013) pubmed
- Infliximab for the treatment of psoriasis. (2006) pubmed
- Infliximab in psoriasis and psoriatic arthritis. (2013) pubmed
- A systematic review on the efficacy and safety of Infliximab in patients with psoriasis. (2016) pubmed
- Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis. (2023) pubmed
- A review of the treatment of psoriasis with infliximab. (2006) pubmed
- Infliximab in dermatological treatment: beyond psoriasis. (2008) pubmed